Who owns Aquestive Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AQST from SEC Form 13F filings across 190 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 190 institutions disclosed 75.5M shares of Aquestive Therapeutics, Inc. worth $356.9M — about 60.1% of shares outstanding; the largest disclosed holder is Bratton Capital Management, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
190
13F holders
$356.9M
value, 2026 filers
60.1%
of shares outstanding (75.5M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of AQST's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Bratton Capital Management, L.P. | 9.8M | $45.4M | 100.0% | 7.8% | 0.0% |
| 2 | BlackRock, Inc. | 8.2M | $38.0M | 0.0% | 6.5% | +1.8% |
| 3 | RTW INVESTMENTS, LP | 7.4M | $34.4M | 0.3% | 5.9% | 0.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.8M | $22.2M | 0.0% | 3.8% | +4.4% |
| 5 | STATE STREET CORP | 3.5M | $16.1M | 0.0% | 2.8% | +18.9% |
| 6 | FEDERATED HERMES, INC. | 3.2M | $14.8M | 0.0% | 2.5% | +2.7% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.9M | $13.4M | 0.0% | 2.3% | +10.4% |
| 8 | SAMSARA BIOCAPITAL, LLC | 2.4M | $11.3M | 1.1% | 1.9% | -2.6% |
| 9 | Rosalind Advisors, Inc. | 2.0M | $9.3M | 3.0% | 1.6% | +700.0% |
| 10 | HRT FINANCIAL LP | 1.8M | $8.3M | 0.0% | 1.4% | +422.5% |
| 11 | TWO SIGMA INVESTMENTS, LP | 1.8M | $8.2M | 0.0% | 1.4% | +38.8% |
| 12 | Blue Owl Capital Holdings LP | 1.4M | $6.4M | 1.2% | 1.1% | +47.5% |
| 13 | Sio Capital Management, LLC | 1.3M | $5.9M | 1.1% | 1% | -14.0% |
| 14 | D. E. Shaw & Co., Inc. | 1.2M | $5.4M | 0.0% | 0.9% | +2988.1% |
| 15 | BANK OF AMERICA CORP /DE/ | 1.1M | $5.3M | 0.0% | 0.9% | -31.9% |
| 16 | Janney Montgomery Scott LLC | 1.1M | $5.1M | 0.0% | 0.9% | +0.2% |
| 17 | BARCLAYS PLC | 1.1M | $4.9M | 0.0% | 0.8% | +5.5% |
| 18 | COMMONWEALTH EQUITY SERVICES, LLC | 1.0M | $4.7M | 0.0% | 0.8% | -2.4% |
| 19 | GOLDMAN SACHS GROUP INC | 997,443 | $4.6M | 0.0% | 0.8% | +112.9% |
| 20 | NORTHERN TRUST CORP | 862,366 | $4.0M | 0.0% | 0.7% | +3.8% |
| 21 | CITADEL ADVISORS LLC | 809,853 | $3.7M | 0.0% | 0.6% | +79.1% |
| 22 | WELLS FARGO & COMPANY/MN | 776,223 | $3.6M | 0.0% | 0.6% | -28.7% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 757,816 | $3.5M | 0.0% | 0.6% | +16.4% |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLC | 743,545 | $3.4M | 0.0% | 0.6% | +1.3% |
| 25 | MILLENNIUM MANAGEMENT LLCNEW | 687,058 | $3.2M | 0.0% | 0.5% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.